Product Information

SIROLIMUS 2 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.3549 per EA under NDC 68462068401. Its NADAC has been published 161 times since Oct 18, 2023.

FDA first approved this application on Oct 16, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SIROLIMUS 2 MG TABLET

sirolimus
$2.3549per EA

Strength

2 mg/1

NDC

68462068401

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

SIROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA208691

FDA Approved

10/16/2020

TE Code

AB

On Market Since

10/16/2020

Pharmacological Classes

Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price Statistics

The NADAC for SIROLIMUS 2 MG TABLET has been published 161 times since Oct 18, 2023, and over the history we have for it it has declined 38.2%. The table below summarizes its recorded NADAC range and movement.

Current price$2.3549 per EA
All-time high$6.0804 (Aug 13, 2025)
All-time low$2.3549 (Oct 21, 2026)
52-week high$4.4187
52-week low$2.3549
Median price$4.3607
Average price$4.3094
Largest weekly change+29.7% (Dec 13, 2023)
Weeks tracked161
Tracking sinceOct 18, 2023

Price History

1W

0.0%

1M

-6.9%

3M

-16.1%

6M

-28.4%

1Y

-51.4%

3Y

-38.2%

5Y

N/A

All

-38.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SIROLIMUS 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 2 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.3549 per EA (NDC 68462068401), effective Nov 11, 2026.

How has the price of SIROLIMUS 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for SIROLIMUS 2 MG TABLET has declined 38.2%. It has been tracked across 161 weekly CMS publications since Oct 18, 2023.

What are the highest and lowest recorded NADAC prices for SIROLIMUS 2 MG TABLET?

Since Oct 18, 2023, the NADAC for SIROLIMUS 2 MG TABLET has ranged from a low of $2.3549 (Oct 21, 2026) to a high of $6.0804 (Aug 13, 2025), with a median of $4.3607 per EA.

Are there cheaper alternatives to SIROLIMUS 2 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SIROLIMUS 2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures SIROLIMUS 2 MG TABLET?

SIROLIMUS 2 MG TABLET (NDC 68462068401) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.